Wu, Y., Gong, L., Xu, J., Mou, Y., Xu, X., & Qian, Z. (2017). The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer. Onco Targets Ther.
Citación estilo ChicagoWu, Yinfang, Lijie Gong, Ji Xu, Yiping Mou, Xiaowu Xu, and Zhenyuan Qian. "The Clinicopathological Significance of HES1 Promoter Hypomethylation in Patients With Colorectal Cancer." Onco Targets Ther 2017.
Cita MLAWu, Yinfang, et al. "The Clinicopathological Significance of HES1 Promoter Hypomethylation in Patients With Colorectal Cancer." Onco Targets Ther 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.